January 11, 2011 – Transplanting their own (autologous) bone marrow-derived stem cells into 48 patients with end-stage liver disease resulted in therapeutic benefit to a high number of the patients, report researchers publishing in the current issue of Cell Transplantation (19:11). “These results suggest that autologous CD34+ stem cell transplantation may be safely administered and appears to offer some therapeutic benefit to patients with both viral and autoimmune-induced end-stage liver disease.”
Read more at: http://phys.org/news/2011-01-cell-transplantation-success-end-stage-liver.html#jCp
Adult Stem Cell Therapy in Liver Insufficiency
{ 0 comments }










